BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9622689)

  • 1. Use of CD34 and factor VIII to diagnose hepatocellular carcinoma on fine needle aspirates.
    Gottschalk-Sabag S; Ron N; Glick T
    Acta Cytol; 1998; 42(3):691-6. PubMed ID: 9622689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
    de Boer WB; Segal A; Frost FA; Sterrett GF
    Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS; Luckasevic TM; Noga CM; Johnson DR; Silverman JF; Liu YL
    Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-color immunostaining of liver fine needle aspiration biopsies with CD34 and carcinoembryonic antigen. Potential utilization in the diagnosis of primary hepatocellular carcinoma vs. metastatic tumor.
    Yoder M; Zimmerman RL; Bibbo M
    Anal Quant Cytol Histol; 2004 Apr; 26(2):61-4. PubMed ID: 15131892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
    Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions. Can they be distinguished on fine needle aspiration biopsy?
    Wee A; Nilsson B
    Acta Cytol; 2003; 47(1):16-26. PubMed ID: 12585026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical staining of Kupffer and endothelial cells in fine needle aspiration cytology of hepatocellular carcinoma.
    Sharifi S; Hayek J; Khettry U; Nasser I
    Acta Cytol; 2000; 44(1):7-12. PubMed ID: 10667152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
    Kandil D; Leiman G; Allegretta M; Trotman W; Pantanowitz L; Goulart R; Evans M
    Cancer; 2007 Oct; 111(5):316-22. PubMed ID: 17763368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic role of glypican 3 and CD34 for differentiating hepatocellular carcinoma from nonmalignant hepatocellular lesions.
    Enan ET; El-Hawary AK; El-Tantawy DA; Abu-Hashim MM; Helal NM
    Ann Diagn Pathol; 2013 Dec; 17(6):490-3. PubMed ID: 24012547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytologic features and histologic correlations of microacinar and microtrabecular types of well-differentiated hepatocellular carcinoma in fine-needle aspiration biopsy.
    Yang GC; Yang GY; Tao LC
    Cancer; 2004 Feb; 102(1):27-33. PubMed ID: 14968415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
    Ahuja A; Gupta N; Kalra N; Srinivasan R; Chawla Y; Rajwanshi A
    Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine needle aspiration diagnosis of hepatocellular carcinoma in metastatic sites.
    Dusenbery D; Carr BI
    Acta Cytol; 1996; 40(3):443-9. PubMed ID: 8669176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples.
    Siddiqui MT; Saboorian MH; Gokaslan ST; Ashfaq R
    Cancer; 2002 Feb; 96(1):49-52. PubMed ID: 11836703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy.
    Kong CS; Appenzeller M; Ferrell LD
    Acta Cytol; 2000; 44(2):218-22. PubMed ID: 10740609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pCEA canalicular immunostaining in fine needle aspiration biopsy diagnosis of hepatocellular carcinoma.
    Wee A; Nilsson B
    Acta Cytol; 1997; 41(4):1147-55. PubMed ID: 9250313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytodiagnosis of hepatocellular carcinoma in fine-needle aspirates of the liver: its differentiation from reactive hepatocytes and metastatic adenocarcinoma.
    Das DK
    Diagn Cytopathol; 1999 Dec; 21(6):370-7. PubMed ID: 10572267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.
    Yao S; Zhang J; Chen H; Sheng Y; Zhang X; Liu Z; Zhang C
    J Histochem Cytochem; 2013 Sep; 61(9):639-48. PubMed ID: 23686365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of CD10 immunohistochemical staining on cellblock in differentiating hepatocellular carcinoma from secondary malignancies of liver.
    Singha J; Khan K; Chatterjee S
    Indian J Pathol Microbiol; 2018; 61(4):510-515. PubMed ID: 30303139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte paraffin-1, CD10, and CD34 immunostaining as a diagnostic aid in cytologic diagnosis of hepatic cancer.
    Agarwal A; Handa U; Kundu R; Sachdev A; Kochhar S
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S434-S438. PubMed ID: 36510999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiomyolipoma of the liver in fine-needle aspiration biopsies: its distinction from hepatocellular carcinoma.
    Cha I; Cartwright D; Guis M; Miller TR; Ferrell LD
    Cancer; 1999 Feb; 87(1):25-30. PubMed ID: 10096356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.